Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,487,074
+$15,237,347 QoQ
Shares Held
1,094,980
+107.5% QoQ
Ownership
0.500%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. RLAY ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,487,074 | 1,094,980 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,249,727 | 527,611 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,504,303 | 296,017 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $794,760 | 152,253 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $598,891 | 173,090 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $721,961 | 275,558 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,414,173 | 343,246 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,357,405 | 191,724 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,234,364 | 189,320 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,389,785 | 287,926 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,051,151 | 186,299 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $512,665 | 60,959 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,445,393 | 194,697 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,810,818 | 170,663 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,930,714 | 263,100 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $456,929 | 20,426 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,082,602 | 64,633 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,487,473 | 116,521 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,894,048 | 94,238 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $343,171 | 10,884 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,120,055 | 30,611 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,495,531 | 43,261 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $349,602 | 8,412 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $22,956 | 539 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||